BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 33974717)

  • 21. Prescription Drug Misuse: Sources of Controlled Medications in Adolescents.
    Schepis TS; Wilens TE; McCabe SE
    J Am Acad Child Adolesc Psychiatry; 2019 Jul; 58(7):670-680.e4. PubMed ID: 30768405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?
    Edlund MJ; Sullivan M; Steffick D; Harris KM; Wells KB
    Pain Med; 2007; 8(8):647-56. PubMed ID: 18028043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescription Drug Misuse Among U.S. Mothers of Minor Children in 2015-2019: Trends, Profiles, and Behavioral Health Comorbidities.
    Oh S; Salas-Wright CP; Vaughn MG; Freisthler B
    J Stud Alcohol Drugs; 2022 Sep; 83(5):712-720. PubMed ID: 36136442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health, Polysubstance Use, and Criminal Justice Involvement Among Adults With Varying Levels of Opioid Use.
    Winkelman TNA; Chang VW; Binswanger IA
    JAMA Netw Open; 2018 Jul; 1(3):e180558. PubMed ID: 30646016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations Between Adolescent Chronic Pain and Prescription Opioid Misuse in Adulthood.
    Groenewald CB; Law EF; Fisher E; Beals-Erickson SE; Palermo TM
    J Pain; 2019 Jan; 20(1):28-37. PubMed ID: 30098405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comprehensive multivariate model of biopsychosocial factors associated with opioid misuse and use disorder in a 2017-2018 United States national survey.
    Montiel Ishino FA; McNab PR; Gilreath T; Salmeron B; Williams F
    BMC Public Health; 2020 Nov; 20(1):1740. PubMed ID: 33208132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Misuse of Prescription and Illicit Drugs in Middle Adulthood in the Context of the Opioid Epidemic.
    Faller RW; Erausquin JT; McCoy TP
    Subst Use Misuse; 2021; 56(2):333-337. PubMed ID: 33325317
    [No Abstract]   [Full Text] [Related]  

  • 28. Persistence/recurrence of and remission from DSM-5 substance use disorders in the United States: Substance-specific and substance-aggregated correlates.
    McCabe SE; West BT; Strobbe S; Boyd CJ
    J Subst Abuse Treat; 2018 Oct; 93():38-48. PubMed ID: 30126540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends and key correlates of prescription opioid injection misuse in the United States.
    Jones CM
    Addict Behav; 2018 Mar; 78():145-152. PubMed ID: 29175290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescription opioid misuse motive latent classes: outcomes from a nationally representative US sample.
    Schepis TS; De Nadai AS; Ford JA; McCabe SE
    Epidemiol Psychiatr Sci; 2020 Jan; 29():e97. PubMed ID: 31992376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonmedical Use of Prescription Opioids among Pregnant U.S. Women.
    Kozhimannil KB; Graves AJ; Levy R; Patrick SW
    Womens Health Issues; 2017; 27(3):308-315. PubMed ID: 28408072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cigarette smoking, prescription opioid use and misuse among young adults: An exploratory analysis.
    Romberg AR; Miller Lo EJ; Barton AA; Xiao H; Vallone DM; Hair EC
    Prev Med; 2019 Dec; 129():105845. PubMed ID: 31518628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adolescent context of exposure to prescription opioids and substance use disorder symptoms at age 35: a national longitudinal study.
    McCabe SE; Veliz P; Schulenberg JE
    Pain; 2016 Oct; 157(10):2173-2178. PubMed ID: 27227693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in Opioid Misuse among Marijuana Users and Non-Users in the U.S. from 2007-2017.
    Azagba S; Shan L; Manzione L; Qeadan F; Wolfson M
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31752436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adults who misuse opioids: Substance abuse treatment use and perceived treatment need.
    Choi NG; DiNitto DM; Marti CN; Choi BY
    Subst Abus; 2019; 40(2):247-255. PubMed ID: 30810503
    [No Abstract]   [Full Text] [Related]  

  • 36. Prescription opioid behaviors among adults with and without disabilities - United States, 2015-2016.
    Lauer EA; Henly M; Brucker DL
    Disabil Health J; 2019 Jul; 12(3):519-522. PubMed ID: 30594480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of Adults Aged ≥18 Years Evaluated for Substance Use and Treatment Planning - United States, 2019.
    Kacha-Ochana A; Jones CM; Green JL; Dunphy C; Govoni TD; Robbins RS; Guy GP
    MMWR Morb Mortal Wkly Rep; 2022 Jun; 71(23):749-756. PubMed ID: 35679167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of Prescription Opioid Medical Use and Misuse Among Parents and Their Adolescent Offspring in the US.
    Griesler PC; Hu MC; Wall MM; Kandel DB
    JAMA Netw Open; 2021 Jan; 4(1):e2031073. PubMed ID: 33410876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binge Drinking and Prescription Opioid Misuse in the U.S., 2012-2014.
    Esser MB; Guy GP; Zhang K; Brewer RD
    Am J Prev Med; 2019 Aug; 57(2):197-208. PubMed ID: 31200998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic Review of Substance Use Measurement Tools in Adolescent and Young Adult Childhood Cancer Survivors.
    Chardon ML; Beal SJ; Breen G; McGrady ME
    J Adolesc Young Adult Oncol; 2022 Aug; 11(4):333-345. PubMed ID: 34550793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.